Beth israel medical center
Brigham and womens hospital
Dana farber cancer institute
Hackensack university medical center
Jacobi medical center
Lenox hill hospital
Montefiore medical center
New york and presbyterian hospital
New york methodist hospital
North shore university hospital
Mount Sinai Medical Center
The miR-17-92 cluster and its target THBS1 are differentially expressed in angiosarcomas dependent on MYC amplification.
Genes Chromosomes Cancer., Jun;51(6):569-78 (2012)
The cyclin-dependent kinase inhibitor flavopiridol potentiates doxorubicin efficacy in advanced sarcomas: preclinical investigations and results of a phase I dose-escalation clinical trial.
Clin. Cancer Res., May;18(9):2638-47 (2012)
Eribulin in soft-tissue sarcomas.
Lancet Oncol., Oct;12(11):988-9 (2011)
Pigmentary changes in a patient treated with imatinib.
J Drugs Dermatol., Sep;10(9):1062-6 (2011)
High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas.
Genes Chromosomes Cancer., Mar;51(3):207-18 (2012)
Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer.
J. Clin. Oncol., Nov;28(33):4985-95 (2010)
Benign mesenchymal stromal cells in human sarcomas.
Clin. Cancer Res., Dec;16(23):5630-40 (2010)
A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites.
Genes Chromosomes Cancer., Aug;50(8):644-53 (2011)
Advances in sarcoma genomics and new therapeutic targets.
Nat. Rev. Cancer., Aug;11(8):541-57 (2011)
Elevations of creatine kinase in patients treated with imatinib mesylate (Gleevec).
Leuk. Res., Jun;34(6):827-9 (2010)
Ifosfamide may be safely used in patients with end stage renal disease on hemodialysis.
Sarcoma., 2009:575629 (2009)
Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor).
Cancer., May;116(9):2258-65 (2010)
IGF2 over-expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting.
J. Pathol., Jul;221(3):300-7 (2010)
ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours.
Nature., Oct;467(7317):849-53 (2010)
A case of high-risk penile epithelioid hemangioendothelioma.
Nat Rev Urol., Apr;6(4):223-7 (2009)
Phase II study of sorafenib in patients with metastatic or recurrent sarcomas.
J. Clin. Oncol., Jul;27(19):3133-40 (2009)
KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors.
Cancer Res., Sep;69(18):7175-9 (2009)
A developmental model of sarcomagenesis defines a differentiation-based classification for liposarcomas.
Am. J. Pathol., Apr;172(4):1069-80 (2008)
Mechanisms of sunitinib resistance in gastrointestinal stromal tumors harboring KITAY502-3ins mutation: an in vitro mutagenesis screen for drug resistance.
Clin. Cancer Res., Nov;15(22):6862-70 (2009)
Perioperative chemotherapy in patients undergoing pulmonary resection for metastatic soft-tissue sarcoma of the extremity : a retrospective analysis.
Cancer., Nov;110(9):2050-60 (2007)